Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries
Andrea Marcellusi, Chiara Bini, Massimo Andreoni, Loredana Sarmati, Jaime Espín, Juan Pablo Horcajada, Thomas Czypionka, Davide Andretta, Paolo Sciattella, Giampiero Favato, Francesco Saverio Mennini
Topics & Concepts
DalbavancinMedicineEmergency medicineEpidemiologyHealth carePublic healthEconomic impact analysisAcute careIntensive care medicineEnvironmental healthVancomycinInternal medicineGeneticsBacteriaCivil engineeringEconomic growthEconomicsStaphylococcus aureusBiologyEngineeringNursingAntimicrobial Resistance in StaphylococcusAntibiotic Use and ResistanceStreptococcal Infections and Treatments